Efficacy, patient‐reported outcomes and safety profile of
            ATX
            ‐101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase
            III
            , randomized, placebo‐controlled study

B. Ascher; K. Hoffmann; P. Walker; S. Lippert; U. Wollina; B. Havlickova

doi:10.1111/jdv.12377

Efficacy, patient‐reported outcomes and safety profile of ATX ‐101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III , randomized, placebo‐controlled study

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.12377 ◽

2014 ◽

Vol 28 (12) ◽

pp. 1707-1715 ◽

Cited By ~ 64

Author(s):

B. Ascher ◽

K. Hoffmann ◽

P. Walker ◽

S. Lippert ◽

U. Wollina ◽

...

Keyword(s):

Safety Profile ◽

Patient Reported Outcomes ◽

Deoxycholic Acid ◽

Phase Iii ◽

Controlled Study ◽

Injectable Drug ◽

Patient Reported ◽

Submental Fat

Download Full-text

Reduction of unwanted submental fat with ATX ‐101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III , randomized, placebo‐controlled study

British Journal of Dermatology ◽

10.1111/bjd.12695 ◽

2014 ◽

Vol 170 (2) ◽

pp. 445-453 ◽

Cited By ~ 68

Author(s):

B. Rzany ◽

T. Griffiths ◽

P. Walker ◽

S. Lippert ◽

J. McDiarmid ◽

...

Keyword(s):

Deoxycholic Acid ◽

Phase Iii ◽

Controlled Study ◽

Treatment Results ◽

Injectable Treatment ◽

Submental Fat

Download Full-text

Poster 156 Dysport®, AbobotulinumtoxinA, Improves Disease-Specific Quality of Life in Patients with Cervical Dystonia, as Measured by Patient-Reported Outcomes, in a Phase III, Randomized, Double-Blind, Placebo-Controlled Study

PM&R ◽

10.1016/j.pmrj.2014.08.550 ◽

2014 ◽

Vol 6 (9) ◽

pp. S239

Author(s):

Philippe Picaut ◽

Doctor of Pharmacy ◽

Werner Poewe ◽

Stanislav Vohanka ◽

Jan Ilkowski ◽

...

Keyword(s):

Quality Of Life ◽

Cervical Dystonia ◽

Patient Reported Outcomes ◽

Phase Iii ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Patient Reported ◽

Disease Specific

Download Full-text

8029 POSTER Health-Related Quality of Life (HRQoL)/Patient Reported Outcomes (PRO) of Patients (pts) With Partially Platinum Sensitive (PPS) Recurrent Ovarian Cancer (ROC) Treated in a Randomized Phase III Trial of Trabectedin and Pegylated Liposomal Doxorubicin (PLD) Vs PLD Alone (OVA-301) – an Exploratory Analysis

European Journal of Cancer ◽

10.1016/s0959-8049(11)72117-7 ◽

2011 ◽

Vol 47 ◽

pp. S536 ◽

Cited By ~ 2

Author(s):

I. Verqote ◽

M. Bidzinski ◽

J. Kelley ◽

S. Vasanthan ◽

I. Runnebaum ◽

...

Keyword(s):

Patient Reported Outcomes ◽

Pegylated Liposomal Doxorubicin ◽

Recurrent Ovarian Cancer ◽

Phase Iii ◽

Phase Iii Trial ◽

Platinum Sensitive ◽

Patient Reported ◽

Related Quality ◽

Health Related

Download Full-text

138PD_PR Patient-reported outcomes (PROs) in ALEX: A phase III study of alectinib (ALEC) vs crizotinib (CRIZ) in non-small-cell lung cancer (NSCLC)

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(18)30412-x ◽

2018 ◽

Vol 13 (4) ◽

pp. S80-S81 ◽

Cited By ~ 1

Author(s):

M. Perol ◽

S. Peters ◽

N. Pavlakis ◽

E. Levchenko ◽

M. Platania ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Patient Reported Outcomes ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Patient Reported ◽

Phase Iii Study

Download Full-text

Patient‐Reported Outcomes and the Association With Clinical Response in Patients With Active Psoriatic Arthritis Treated With Golimumab: Findings Through 2 Years of a Phase III, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial

Arthritis Care & Research ◽

10.1002/acr.22044 ◽

2013 ◽

Vol 65 (10) ◽

pp. 1666-1673 ◽

Cited By ~ 16

Author(s):

Arthur Kavanaugh ◽

Iain B. McInnes ◽

Gerald G. Krueger ◽

Dafna Gladman ◽

Anna Beutler ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Clinical Response ◽

Patient Reported Outcomes ◽

Controlled Trial ◽

Phase Iii ◽

Double Blind ◽

Double Blind Placebo ◽

Patient Reported

Download Full-text

Patient Reported Outcomes of NRG Oncology/RTOG 0232: A Phase III Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy with Brachytherapy Alone in Intermediate Risk Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2018.06.103 ◽

2018 ◽

Vol 102 (3) ◽

pp. S2-S3 ◽

Cited By ~ 3

Author(s):

D.W. Bruner ◽

J. Moughan ◽

B.R. Prestidge ◽

M.G. Sanda ◽

W. Bice ◽

...

Keyword(s):

Prostate Cancer ◽

Patient Reported Outcomes ◽

Phase Iii ◽

External Beam Radiation ◽

External Beam ◽

Intermediate Risk ◽

Beam Radiation ◽

Patient Reported ◽

Risk Prostate Cancer ◽

Phase Iii Study

Download Full-text

Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritis

RMD Open ◽

10.1136/rmdopen-2016-000410 ◽

2017 ◽

Vol 3 (1) ◽

pp. e000410 ◽

Cited By ~ 14

Author(s):

Paul Emery ◽

Ricardo Blanco ◽

Jose Maldonado Cocco ◽

Ying-Chou Chen ◽

Carol L Gaich ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Patient Reported Outcomes ◽

Phase Iii ◽

Refractory Rheumatoid Arthritis ◽

Patient Reported ◽

Phase Iii Study

Download Full-text

Tofacitinib (CP-690,550), an oral Janus kinase inhibitor, improves patient-reported outcomes in a phase 2b, randomized, double-blind, placebo-controlled study in patients with moderate-to-severe psoriasis

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.12081 ◽

2013 ◽

Vol 28 (2) ◽

pp. 192-203 ◽

Cited By ~ 38

Author(s):

C. Mamolo ◽

J. Harness ◽

H. Tan ◽

A. Menter

Keyword(s):

Patient Reported Outcomes ◽

Kinase Inhibitor ◽

Severe Psoriasis ◽

Janus Kinase ◽

Controlled Study ◽

Double Blind ◽

Janus Kinase Inhibitor ◽

Double Blind Placebo ◽

Patient Reported

Download Full-text

Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials

American Journal of Clinical Dermatology ◽

10.1007/s40257-018-0395-0 ◽

2018 ◽

Vol 20 (1) ◽

pp. 135-145 ◽

Cited By ~ 9

Author(s):

David M. Pariser ◽

Adelaide A. Hebert ◽

Janice Drew ◽

John Quiring ◽

Ramanan Gopalan ◽

...

Keyword(s):

Randomized Controlled Trials ◽

Patient Reported Outcomes ◽

Phase Iii ◽

Controlled Trials ◽

Axillary Hyperhidrosis ◽

Randomized Controlled ◽

Patient Reported

Download Full-text

Acute Cystitis Symptom Score questionnaire for measuring patient-reported outcomes in women with acute uncomplicated cystitis: Clinical validation as part of a phase III trial comparing antibiotic and nonantibiotic therapy

Investigative and Clinical Urology ◽

10.4111/icu.20200060 ◽

2020 ◽

Vol 61 (5) ◽

pp. 498

Author(s):

Jakhongir F. Alidjanov ◽

Andre Overesch ◽

Dimitri Abramov-Sommariva ◽

Martina Hoeller ◽

Hubert Steindl ◽

...

Keyword(s):

Symptom Score ◽

Patient Reported Outcomes ◽

Phase Iii ◽

Clinical Validation ◽

Acute Cystitis ◽

Phase Iii Trial ◽

Patient Reported ◽

Acute Uncomplicated Cystitis ◽

Uncomplicated Cystitis

Download Full-text